ACRS · Aclaris Therapeutics, Inc. · Share Buybacks
$3.90
+0.09 (+2.23%)
At close · Oct 22
Return incl. dividend (before tax)
Market Cap
$570.40M
Shares
147.20M
Volume · Oct 22
852.34K
Avg daily vol (3M)
2.74M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-02-27 | 2026-08-06 | $100,000,000 | — | — | 8-K , filed 2026-08-06 |
Key facts
CIK
1557746
CUSIP
00461U105
13F (30d)
13 filings
13 filers
Visit website
Investor relations